CELH
Celsius Holdings, Inc.
CELH has the edge over PSMT overall, supported by stronger valuation and stronger fundamentals.
PSMT
PriceSmart, Inc.
PSMT has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PSMT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
PSMT's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over PSMT in the historical PE scenario, which offers more potential upside but is not a forecast.
PSMT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $109 | -34% |
| Fair | 23x | $122 | -26% |
| Forward | 28x | $164 | — |
| Current | 30x | $164 | — |
| Expensive | 31x | $167 | +1.5% |
Historical ranges are pointers, not guarantees.
PSMT's PE is in its expensive range at 30x. If earnings grow as analysts expect, today's price would be 28x next year's earnings.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over PSMT on the outlook, with more favorable profitability expectations.
PSMT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for PSMT, with profitability holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
PSMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.97 | +11% |
| Q3 2026 | $5.40 | +12% |
| Q2 2026 | $5.21 | +9.9% |
| Q1 2026 | $5.07 | +8.3% |
| Q4 2025 | $4.90 | +7.9% |
| Q3 2025 | $4.82 | +5.5% |
| Q2 2025 | $4.74 | +15% |
| Q1 2025 | $4.68 | +18% |
| Q4 2024 | $4.54 | +23% |
PSMT has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over PSMT on profitability, with a higher operating margin.
PSMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +14% |
| Q2 2026 | $1.5B | +12% |
| Q1 2026 | $1.5B | +9.7% |
| Q4 2025 | $1.4B | +9.9% |
| Q3 2025 | $1.3B | +8.6% |
| Q2 2025 | $1.3B | +7.1% |
| Q1 2025 | $1.4B | +5.6% |
| Q4 2024 | $1.3B | +7.8% |
PSMT's revenue has grown year over year every quarter since late 2020: $1.5B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.8% | -0.2 points |
| Q2 2026 | 4.4% | +0.2 points |
| Q1 2026 | 5% | +0.3 points |
| Q4 2025 | 4.5% | -0.1 points |
| Q3 2025 | 4% | 0 points |
| Q2 2025 | 4.3% | +0.2 points |
| Q1 2025 | 4.8% | -0.1 points |
| Q4 2024 | 4.6% | -0.4 points |
PSMT's operating margin was 3.8% last quarter, about level with the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
PSMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $48.3M | +89% |
| Q2 2026 | $3.2M | -77% |
| Q1 2026 | $12.3M | -77% |
| Q4 2025 | $32.6M | +215% |
| Q3 2025 | $25.6M | +69% |
| Q2 2025 | $14M | +$14.3M |
| Q1 2025 | $53.2M | +225% |
| Q4 2024 | $10.3M | +33% |
PSMT has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over PSMT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
PSMT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -26K shares |
| 1 year | +0.6% | +181K shares |
| 3 years | -1.8% | -542K shares |
| 5 years | -0.5% | -159K shares |
| Available history | -0.1% | -40K shares |
PSMT has 30M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $177,000 |
| Q2 2026 | $113,000 |
| Q1 2026 | $3.7M |
| Q4 2025 | $5.1M |
| Q3 2025 | $853,000 |
| Q2 2025 | $105,000 |
| Q1 2025 | $2.5M |
| Q4 2024 | $3.3M |
PSMT spent $9M buying back its own shares over the past year, up 35% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
PSMT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | 0.0x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | 0.0x | Very low |
PSMT has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
PSMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.7 | Neutral |
| Stochastic | 14.7 | Oversold |
PSMT's weekly RSI is 46 (neutral) and its Stochastic is 15 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
PSMT PE vs Consumer Defensive Sector
| Metric | PSMT | Sector median | Relative |
|---|---|---|---|
| PE | 30x | 19x | 56% above |
| PE % | 81 | 18 | 63 pts above |
PSMT has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
PSMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $168.5 | 2.4% below |
| 20 week MA | $176.1 | 6.6% below |
| 50 week MA | $161.8 | 1.7% above |
| 100 week MA | $132.6 | 24% above |
| 200 week MA | $105.8 | 55% above |
PSMT has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
PSMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $72.1 | $89.9 | +25% |
| 2021 | $89.9 | $72.1 | -20% |
| 2022 | $72.1 | $62.9 | -13% |
| 2023 | $62.9 | $75.8 | +21% |
| 2024 | $75.8 | $93.0 | +23% |
| 2025 | $93.0 | $125.0 | +34% |
| 2026 YTD | $125.0 | $164.5 | +32% |
PSMT has the edge over CELH on returns for 2026, with the stronger performance.